Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin

Inclusion Criteria: * with a history of hypertension treated with medication and blood pressure management ( a systolic blood-pressure target of 140 to 179 mmHg and a diastolic blood-pressure target of 70 to 100 mmHg) during the period of hospitalization, * the site of hematoma located in one of the cerebral hemispheres, * hematoma volume 10-30ml, * no blood in the ventricles, * within 24 hours of onset of first-time acute intracerebral hemorrhage, * no loss of consciousness (drowsiness acceptable). Exclusion Criteria: * cerebellar or brainstem hemorrhage, * intracerebral hemorrhage caused by bleeding diathesis, aneurysms, vascular malformations, improperly using anticoagulant drugs, or suspicious amyloid angiopathy, * subarachnoid hemorrhage; multifocal hemorrhage, * mixed stroke or hemorrhagic infarct, * coexisting systematic diseases such as heart or kidney failure, tumors, gastrointestinal hemorrhage and so on, * pregnant or lactating women, * a history of XUESAITONG injection anaphylaxis.